Quantcast
Last updated on April 16, 2014 at 17:27 EDT

Latest MS Stories

2013-04-19 18:02:46

A major Nordic research project involving researchers from the University of Copenhagen has, for the first time ever, mapped the use of alternative treatment among multiple sclerosis patients - knowledge which is important for patients with chronic disease and the way in which society meets them. People with multiple sclerosis (MS) often use alternative treatments such as dietary supplements, acupuncture and herbal medicine to facilitate their lives with this chronic disease. This is the...

2013-04-16 08:28:33

-- 65 new grants and fellowships part of 2013 investment of over $47 million in cutting-edge research projects moving us closer to a world free of MS NEW YORK, April 16, 2013 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has committed another $18 million to support up to 65 new MS research projects. These new awards are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever. (Logo:...

2013-04-15 08:30:12

CHICAGO, April 15, 2013 /PRNewswire-iReach/ -- Becker's Hospital Review has published its list, "50 Experts Leading the Field of Patient Safety." This list recognizes advocates, professors, researchers, administrators and healthcare providers who have won awards, published articles, spoken out and led initiatives to reduce harm and ensure safety. The Becker's Hospital Review editorial team evaluated individuals committed to patient safety at national organizations, universities and...

2013-04-10 23:02:54

According to Ironclad Integrity Ltd MS natural treatments have become all the rage lately as these promise effective results, no side-effects and lower health care bills. The company has released via http://www.SclerosisTreatment.com reviews and price analysis for the most popular MS alternative therapies. Denver, Colorado (PRWEB) April 10, 2013 Health organizations estimate there are about 400,000 Multiple Sclerosis patients in the United States today, but that number is certainly higher...

2013-04-09 18:16:56

Newborn babies' immune system development and levels of vitamin D have been found to vary according to their month of birth, according to new research. The research, from scientists at Queen Mary, University of London and the University of Oxford, provides a potential biological basis as to why an individual's risk of developing the neurological condition multiple sclerosis (MS) is influenced by their month of birth. It also supports the need for further research into the potential...

2013-04-09 12:29:09

BROOMFIELD, Colo., April 9, 2013 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today a study in collaboration with the University of Miami Miller School of Medicine. The study will examine the effects of Accera's medical food, Axona, on cognitive impairment in patients with multiple sclerosis (MS). Axona is a...

2013-04-05 08:23:02

People living with multiple sclerosis (MS) and MS experts available to speak about the importance of NIH funding for life-changing MS research WASHINGTON, April 5, 2013 /PRNewswire-USNewswire/ -- On April 8 at 11 a.m., thousands of people will gather on the Carnegie Library grounds to participate in the Rally for Medical Research to raise awareness of the critical need to make funding for the National Institutes of Health (NIH) a priority. The National MS Society and nearly 200 other...

2013-04-03 23:03:21

Oral disease-modifying drugs are recent additions to the multiple sclerosis market. New York, NY (PRWEB) April 03, 2013 Multiple sclerosis patients who are taking oral disease-modifying drugs (DMD) are more optimistic about their future expectations for their disease than patients who are taking non-oral DMDs, according to new research from Kantar Health, a leading global healthcare advisory firm. More than 950 MS patients were asked to predict whether they expected their disease to...

2013-04-03 23:03:05

Dr. Saud A. Sadiq to Discuss Cellular Therapy for MS at the Second International Adult Stem Cell Conference: Regenerative Medicine — A Fundamental Shift in Science and Culture. New York, NY (PRWEB) April 03, 2013 The Tisch MS Research Center of New York announced today that Dr. Saud A. Sadiq has accepted an invitation to participate in the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture to be held within the Vatican,...

2013-03-22 09:45:11

Atrophy of the thalamus is an important predictor of clinically definite MS, study shows A growing body of research by multiple sclerosis (MS) investigators at the University at Buffalo and international partners is providing powerful new evidence that the brain´s gray matter reflects important changes in the disease that could allow clinicians to diagnose earlier and to better monitor and predict how the disease will progress. Over the past three years, the UB researchers and...